Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

GHRH antagonists support lung endothelial barrier function.

Uddin MA, Akhter MS, Singh SS, Kubra KT, Schally AV, Jois S, Barabutis N.

Tissue Barriers. 2019;7(4):1669989. doi: 10.1080/21688370.2019.1669989. Epub 2019 Oct 3.

PMID:
31578921
2.

Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models.

Chamcheu JC, Esnault S, Adhami VM, Noll AL, Banang-Mbeumi S, Roy T, Singh SS, Huang S, Kousoulas KG, Mukhtar H.

Cells. 2019 Sep 15;8(9). pii: E1089. doi: 10.3390/cells8091089.

3.

Genotype Driven Therapy for Non-Small Cell Lung Cancer: Resistance, Pan Inhibitors and Immunotherapy.

Singh SS, Dahal A, Shrestha L, Jois SD.

Curr Med Chem. 2019 Feb 22. doi: 10.2174/0929867326666190222183219. [Epub ahead of print]

PMID:
30854949
4.

Synthesis, Characterization, and Evaluation of Near-IR Boron Dipyrromethene Bioconjugates for Labeling of Adenocarcinomas by Selectively Targeting the Epidermal Growth Factor Receptor.

Kaufman NEM, Meng Q, Griffin KE, Singh SS, Dahal A, Zhou Z, Fronczek FR, Mathis JM, Jois SD, Vicente MGH.

J Med Chem. 2019 Apr 11;62(7):3323-3335. doi: 10.1021/acs.jmedchem.8b01746. Epub 2019 Mar 25.

5.

Homo- and Heterodimerization of Proteins in Cell Signaling: Inhibition and Drug Design.

Singh SS, Jois SD.

Adv Protein Chem Struct Biol. 2018;111:1-59. doi: 10.1016/bs.apcsb.2017.08.003. Epub 2017 Oct 6. Review.

Supplemental Content

Loading ...
Support Center